Свободный билирубин как предиктор нейротоксичности: вопрос будущего?
DOI:
https://doi.org/10.15574/PP.2018.76.67Ключевые слова:
свободный билирубин, желтуха, менеджмент, новорожденный, окислительный стресс, фототерапияАннотация
Свободный билирубин является относительно новым маркером, который более информативен при оценке риска нейротоксичности билирубина. Этот маркер в будущем может быть полезным для менеджмента желтухи новорожденных, а также использоваться в качестве одного из критериев для операции заместительного переливания крови. Он представляет собой фракцию билирубина в сыворотке или плазме, которая не связана с белками и лучше проходит через гематоэнцефалический барьер. В ближайшем будущем вероятно изменятся взгляды на интерпретацию некоторых биохимических параметров, и для оценки риска нейротоксичности будет недостаточно использовать только показатель общего билирубина, особенно у недоношенных новорожденных. Самым большим препятствием для использования и введения этого маркера в клиническую практику является необходимость адаптации метода для повседневного использования. Результаты клинических исследований и накопленные данные позволяют предположить ускоренную интеграцию этого параметра в рутинный протокол менеджмента желтухи новорожденных.
Библиографические ссылки
Ahlfors CE, Amin SB, Parker AE. (2009). Unbound bilirubin predicts abnormal automated auditory brainstem response in a diverse newborn population. J Perinatol. 29: 305–309. https://doi.org/10.1038/jp.2008.199; PMid:19242487 PMCid:PMC4285409
Ahlfors CE, Bhutani VK, Wong RJ, Stevenson DK. (2018, Jul 2). Bilirubin binding in jaundiced newborns: from bench to bedside? Pediatr Res. https://doi.org/10.1038/s41390-018-0010-3.
Ahlfors CE, Marshall GD, Wolcott DK, Olson DC, Van Overmeire B. (2006). Measurement of unbound bilirubin by the peroxidase test using Zone Fluidics. Clin Chim Acta. 365(1–2): 78–85. https://doi.org/10.1016/j.cca.2005.07.030; PMid:16168977
Amin SB, Charafeddine L, Guillet R. (2005). Transient bilirubin encephalopathy and apnea of prematurity in 28 to 32 weeks gestational age infants. J Perinatol. 25(6): 386–390. https://doi.org/10.1038/sj.jp.7211295; PMid:15843815
Amin SB, Saluja S, Saili A, et al. (2017). Chronic Auditory Toxicity in Late Preterm and Term Infants With Significant Hyperbilirubinemia. Pediatrics. 140(4). https://doi.org/10.1542/peds.2016-4009; PMid:28954873 PMCid:PMC5613832.
Amin SB, Wang H. (2018). Bilirubin Albumin Binding and Unbound Unconjugated Hyperbilirubinemia in Premature Infants. J Pediatr. 192: 47–52. https://doi.org/10.1016/j.jpeds.2017.09.039; PMid:29132818 PMCid:PMC5732858
Amin SB. (2004). Clinical assessment of bilirubin-induced neurotoxicity in premature infants. Semin Perinatol. 28(5): 340—347. https://doi.org/10.1053/j.semperi.2004.09.005; PMid:15686265
Andreu Y, Ostra M, Ubide C, Galban J, de Marcos S, Castillo JR. (2002). Study of a fluorometricenzymatic method for bilirubin based on chemically modified bilirubin-oxidase and multivariate calibration. Talanta. 57(2): 343–353. https://doi.org/10.1016/S0039-9140(02)00023-1
Basu S, DE, D, Dev Khanna H, et al. (2014, Jul). Lipid peroxidation, DNA damage and total antioxidant status in neonatal hyperbilirubinemia. J Perinatol. 34(7): 519–23. https://doi.org/10.1038/jp.2014.45 [Epub ahead of print]
Bratlid D. (1990). How bilirubin gets into the brain. Clin Perinatol. 17(2): 449–465. https://doi.org/10.1016/S0095-5108(18)30578-5
Calligaris SD, Bellarosa C, Giraudi P, Wennberg RP, Ostrow JD, Tiribelli C. (2007). Cytotoxicity is predicted by unbound and not total bilirubin concentration. Pediatr Res. 62(5): 576–580. https://doi.org/10.1203/PDR.0b013e3181568c94; PMid:18049372
Daneman R. (2012). The blood-brain barrier in health and dissease. Ann Neurol. 72(5):648–672. https://doi.org/10.1002/ana.23648; PMid:23280789
Demova K, Fussiova M, Kovacsova M. (2017). Novorodenecka zltacka, Pediatr prax. 18(2): 51–58.
Gamaleldin R, Iskander I, Seoud I et al. (2011). Risk factors for neurotoxicity in newborns with severe neonatal hyperbilirubinemia. Pediatrics. 128(4): e925–e931. https://doi.org/10.1542/peds.2011-0206;PMid:21911352
Gupta N, Singh T, Chaudhary R et al. (2016). Bilirubin in coronary artery disease: Cytotoxic or protective? World J Gastrointest Pharmacol Ther. 7(4): 469–476. https://doi.org/10.4292/wjgpt.v7.i4.469; PMid:27867680
Hegyi T, Kleinfeld A, Huber A et al. (2018, Mar. 12). Unbound bilirubin measurements by a novel probe in preterm infants. J Matern Fetal Neonatal Med: 1–6. https://doi.org/10.1080/14767058.2018.1448380
Jacobsen J, Wennberg RP. (1974). Determination of unbound bilirubin in the serum of newborns. Clin Chem. 20(7): 783. PMid:4835230
Jon F. Watchko. (2016). Measurement of Circulating Unbound Bilirubin: Will It Ever Be a Part of Routine Neonatal Care? The Journal of Pediatrics. 173: 6–7. https://doi.org/10.1016/j.jpeds.2016.03.044; PMid:27063804
Lakowicz JR. (2001). Radiative decay engineering: biophysical and biomedical applications. Anal Biochem. 298(1): 1–24. https://doi.org/10.1006/abio.2001.5377; PMid:11673890
Letamendia-Richard E, Ammar RB, Tridente A, De Luca D. (2016). Relationship between transcutaneous bilirubin and circulating unbound bilirubin in jaundiced neonates. Early Hum Dev. 103: 235–239. https://doi.org/10.1016/j.earlhumdev.2016.10.005; PMid:27838549
Martelanca M, Ziberna L, Passamonti S, Franko M. (2014). Direct determination of free bilirubin in serum at sub-nanomolar levels. Analytica Chimia Acta. 809: 174–182. https://doi.org/10.1016/j.aca.2013.11.041; PMid:24418149
McDonagh AF, Vreman HJ, Wong RJ, Stevenson DK. (2009). Photoisomers: obfuscating factors in clinical peroxidase measurements of unbound bilirubin? Pediatrics. 123(1): 67–76. https://doi.org/10.1542/peds.2008-0492; PMid:19117862
Morioka I. (2018). Hyperbilirubinemia in preterm infants in Japan: New treatment criteria. Pediatrics International. 60: 684–690. https://doi.org/10.1111/ped.13635; PMid:29906300
Muoio V, Persson PB, Sendeski MM. (2014). The neurovascular unit — concept review. Acta Physiol (Oxf). 210(4): 790—798. https://doi.org/10.1111/apha.12250; PMid:24629161
Nag N, Halder S, Chaudhuri R et al. (2009). Role of bilirubin as antioxidant in neonatal jaundice and effect of ethanolic extract of sweet lime peel on experimentally induced jaundice in rat. Indian Journal of Biochemistry & Biophysics. 46: 73—78. PMid:19374257
Nakamura H, Yonetani M, Uetani Y, Funato M, Lee Y. (1992). Determination of serum unbound bilirubin for prediction of kernicterus in low birthweight infants. Acta Paediatr Jpn. 34(6): 642–647. https://doi.org/10.1111/j.1442-200X.1992.tb01024.x; PMid:1285512
Ostrow JD, Mukerjee P, Tiribelli C. (1994). Structure and binding of unconjugated bilirubin: relevance for physiological and pathophysiological function. J Lipid Res. 35(10): 1715—1737. PMid:7852850
Pi’ha J. (2014). Bariery nervoveho systemu za fyziologickych a patologickych stavuю Cesk Slov Neurol. 77; 110(5): 553–559.
Raye-Ann deRegnier. (2018). The uncomfortable problem of unbound bilirubin in extremely preterm infants. The Journal of Pediatrics. 192: 1. https://doi.org/10.1016/j.jpeds.2017.11.002; https://doi.org/10.1016/j.jpeds.2018.03.019; https://doi.org/10.1016/j.jpeds.2018.09.014
Ruud Hansen TW. (2015). Phototherapy for neonatal jaundice — therapeutic effects on more than one level? Semin Perinatol. 34(3): 231—234. https://doi.org/10.1053/j.semperi.2010.02.008; PMid:20494740
Sanjiv B, Amin MD et al. (2011). Newborn Jaundice Technologies: Unbound Bilirubin and Bilirubin Binding Capacity In Neonates, Semin Perinatol. 35(3): 134—140. https://doi.org/10.1053/j.semperi.2011.02.007; PMid:21641486
Sgro M, Campbell D, Shah V. (2006). Incidence and causes of severe neonatal hyperbilirubinemia in Canada. CMAJ. 175(6): 587—590. https://doi.org/10.1503/cmaj.060328; PMid:16966660
Shapiro SM. (2003). Bilirubin toxicity in the developing nervous system. Pediatr Neurol. 29(5): 410–421. https://doi.org/10.1016/j.pediatrneurol.2003.09.011; PMid:14684236
Shekeeb Shahab M, Kumar P et al. (2008). Evaluation of oxidant and antioxidant status in term neonates: A plausible protective role of bilirubin. Mol Cell Biochem. 317(1–2): 51–59. https://doi.org/10.1007/s11010-008-9807-4; PMid:18560765
Shimabuku R, Nakamura H. (1982). Total and unbound bilirubin determination using an automated peroxidase micromethod. Kobe J Med Sci. 28(2): 91–104. PMid:6285074
Stark AM, Bhutani VK. (2017). Neonatal hyperbilirubinemia. In: Cloherty and Stark's Manual of Neonatal Care. 8th ed. Lippincott Williams & Wilkins: 335–352. PMid:28509628
Tilling T, Engelbertz C, Decker S, Korte D, Huwel S, Galla HJ. (2002). Expression and adhesive properties of basement membrane proteins in cerebral capillary endothelial cell cultures. Cell Tissue Res. 310(1): 19–29. https://doi.org/10.1007/s00441-002-0604-1; PMid:12242480
Vitek L, Jirsa Jr M, Brodanova M et al. (2002). Gilbert Syndrome and Ischemic Heart Disease: A Protective Effect of Elevated Bilirubin Levels. Atherosclerosis. 160(2): 449–456. https://doi.org/10.1016/S0021-9150(01)00601-3
Volpe J. (2001). Bilirubin and brain injury. In: Neurology of the Newborn. 5th ed. Philadelphia: Saunders Elseveir: 619–651.
Wang X, Chowdhury JR et al. (2006). Bilirubin metabolism: Applied physiology Current. Paediatrics. 16: 70–74. https://doi.org/10.1016/j.metabol.2006.06.019; PMid:17046551
Wong AD, Ye M, Levy AF, Rothstein JD, Bergles DE, Searson PC. (2013). The blood-brain barrier: an engineering perspective. Front Neuroeng. 6: 7. https://doi.org/10.1182/blood-2012-10-462655; https://doi.org/10.1182/blood-2012-06-434373; https://doi.org/10.1182/blood-2013-05-503359; https://doi.org/10.1182/blood-2013-03-489641; https://doi.org/10.1182/blood-2012-12-475863; https://doi.org/10.1182/blood-2013-07-511170; https://doi.org/10.1182/blood-2012-06-436691; https://doi.org/10.1182/blood-2012-10-460618; https://doi.org/10.1182/blood-2012-11-467787; https://doi.org/10.1182/blood-2012-08-451765; https://doi.org/10.1182/blood-2013-06-506691; https://doi.org/10.1182/blood-2013-05-499806; https://doi.org/10.1182/blood-2012-07-445205; PMid:23372168 PMCid:PMC3617636
Ziberna L, Martelanc M et al. (2016). Bilirubin is an Endogenous Antioxidant in Human Vascular Endothelial Cells, Scientific Reports. 6: 29240. https://doi.org/10.1038/srep29240; PMid:27381978 PMCid:PMC4933905